General Healthcare News
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense. A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of...
At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared With 14.1 Percent of Placebo-Treated Patients Who were Hospitalized or Died Merck Plans to Seek Emergency Use Authorization...
(RTTNews) - As we head into the fourth quarter of 2021, here is a recap of what happened on the regulatory front this month that caught our attention. Samsung Bioepis' Byooviz became the first biosimilar for Lucentis to treat macular...
CAMBRIDGE, Mass. — At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize...
Small Business Innovation Research Program Seed Funding will Support R&D to Improve Coronavirus Testing Methodology BALTIMORE--(BUSINESS WIRE)--xMD Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business...
AIRA Matrix, the premier provider of Artificial Intelligence (AI) products and services in Digital Pathology has been selected in the 3rd cohort of the GE Healthcare India Edison™ Accelerator Program. The GE Healthcare India...
